Lipidomics is systems-level analysis and characterization of lipids and their interacting moieties. The amount of information in the genomic and proteomic fi elds is greater than that in the lipidomics fi eld, because of the complex nature of lipids and the limitations of tools for analysis. The main innovation during recent years that has spurred advances in lipid analysis has been the development of new mass spectroscopic techniques, particularly the " soft ionization " techniques electrospray ionization and matrix-assisted laser desorption/ionization. Lipid metabolism may be of particular importance for the central nervous system, as it has a high concentration of lipids. The crucial role of lipids in cell signaling and tissue physiology is demonstrated by the many neurological disorders, including bipolar disorders and schizophrenia, and neurodegenerative diseases such as Alzheimer ' s, Parkinson ' s, and Niemann-Pick diseases, that involve deregulated lipid metabolism. Altered lipid metabolism is also believed to contribute to cerebral ischemic (stroke) injury. Lipidomics will provide a molecular signature to a certain pathway or a disease condition. Lipidomic analyses (characterizing complex mixtures of lipids and identifying previously unknown changes in lipid metabolism) together with RNA silencing, using small interfering RNA (siRNA), may provide powerful tools to elucidate the specifi c roles of lipid intermediates in cell signaling and open new opportunities for drug development.
INTRODUCTION
Phospholipids are important components of all mammalian cells and have a variety of biological functions: (1) they form lipid bilayers that provide structural integrity necessary for protein function, (2) they function as an energy reservoir (eg, triglycerides), and (3) they serve as precursors for various second messengers such as arachidonic acid, docosahexaenoic acid, ceramide, 1,2-diacylglycerol, phosphatidic acid, and lyso-phosphatidic acid. A deeper knowledge of the complexity of phospholipid metabolism will elevate our understanding of the role of lipids in maintaining normal cell physiology and how alterations in lipid metabolism contribute to various disease states.
DEFINING A LIPID
Lipids comprise an enormous number of chemically distinct molecules arising from combinations of fatty acids with various backbone structures. Indeed, it is diffi cult to defi ne what lipids are. Defi ning lipids as a class of biological molecules that share a high degree of solubility in organic solvents is considered at once too broad and too narrow, encompassing structurally and functionally unrelated molecules and excluding lipids, such as gangliosides and phosphoinositides, that have some water solubility. 1 More acceptable is the defi nition of lipids as fatty acids and their derivatives, and substances related biosynthetically or functionally to these compounds. Lipids are currently classifi ed into 8 categories -fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides -containing distinct classes and subclasses of molecules. 2 Random permutation of fatty acids with various backbone positions and com bination with different head groups would theoretically produce thousands of lipid species. However, the nonrandom distribution in biological systems generates a much smaller number of molecular species than is theoretically possible. Still, ~100 molecular species can be experimentally observed in a given class of glycerophospholipids from crude tissue extracts. 3 It has been estimated that 300 to 400 distinct species of sphingolipids exist in human tissue. 4 Overall, mammalian cells may contain ~1000 to 2000 lipid species, not counting peroxidized or damaged lipids. 3 
CONVENTIONAL LIPID ANALYSES
The " classical " methods of lipid analysis usually involve solvent extraction of the source material followed by separation of lipids by thin-layer chromatography (TLC) or highperformance liquid chromatography (HPLC). Following TLC separation, lipid classes are identifi ed in reference to a chromatography standard. Fatty acids of the various lipids can be converted to methyl esters and quantitated by gas chromatography with detection by either fl ame ionization or mass analysis. Phospholipids can also be quantitated by phosphorous assays, which determine the amount of phospholipid but do not provide information on the fatty acid composition. Detection of lipids following HPLC is typically accomplished by refractive index measurements or mass analysis. These methods have the advantage of being well established for many classes of lipids. Some of these aspects have been recently reviewed. 5 However, because of the complexity of lipids and the fact that many biologically active lipid species are present in very small amounts, conventional techniques of lipid analysis are often limited by lack of sensitivity and insuffi cient resolution. These methods are also laborintensive, often requiring sample purifi cation and/or derivatization prior to analysis, thus limiting sample throughput.
LIPIDOMICS
The emerging fi eld of lipidomics ( Figure 1 ) tries to defi ne the crucial role of lipids in the cell; the research is aimed at mapping the entire lipid population in a biological system, describing the composition and biological function. 3 , 6-8 Lipidomics will provide a molecular signature to a certain pathway or a disease condition. The role of lipids in the formation of cell membranes makes them both ligand and substrate for proteins, suggesting that advances in lipidomics could have far-reaching implications for genomics, proteomics, and metabolomics. In 2004 the National Institute on Drug Abuse sponsored a meeting entitled Targeted Lipidomics: Signaling Lipids and Drugs of Abuse (Washington, DC, 15 to 17 April), organized by Dr Rao Rapaka; the published proceedings from the meeting contain further information and references. 9 Advances have been made in genomics (5 building blocks) and proteomics (20 building blocks); however, similar advances have not occurred in lipidomics because of the complex nature of lipids and the limitations of tools for analysis. Despite these setbacks, there have been impressive achievements during the last few years. [10] [11] [12] [13] [14] [15] The main progress that has spurred advances in lipid analysis has been the development of new mass spectroscopic (MS) techniques, particularly the " soft ionization " techniques electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). Conventional mass spectral analyses used electron impact ionization, a method widely employed for small, volatile molecules but not applicable to complex biological molecules. Other ionization techniques such as fi eld desorption, chemical ionization, and fast atom bombardment have been introduced over the past 30 years but have had experimental limitations, including procedural complexity, poor reproducibility, the need for particular derivatization procedures, inherent matrix background signals, and only moderate sensitivity. 16 These techniques also can give rise to substantial fragmentation, so the molecular ion of the analyte is not detected. Both ESI and MALDI enable the analysis of high-molecular-weight Figure 1 . Evolution of genomics to lipidomics through proteomics and metabolomics. Genomics : mapping the entire genome (DNA and RNA sequences). Proteomics : identifying, sequencing and characterizing the functional protein network (the " proteome " or protein complement generated from the genome). Metabolomics : the comprehensive analysis of the whole metabolome under a given set of conditions. Lipidomics : the systems-level analysis and characterization of total lipids and their interacting moieties. TLC indicates thin-layer chromatography; HPLC, high-performance liquid chromatography; GC, gas chromatography; ESI-tandem MS, electrospray ionization -tandem mass spectroscopy; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-fl ight mass spectroscopy; NMR, nuclear magnetic resonance. Modifi ed from Wenk. 3 E316 biomolecules without major degradation and, therefore, with a high probability of detecting the molecular ion. These methods also provide high sensitivity, and lipid analyses can be achieved with submicrogram samples. Comprehensive reviews of ESI-MS 16 , 17 and MALDI-TOF (time-offl ight) MS 18 and their application to lipidomics have been published.
LIPIDOMICS AND THE BRAIN

Central Nervous System Disorders
The crucial role of lipids in cell signaling and tissue physiology is demonstrated by the large number of diseases and neurological disorders in which lipid metabolism is altered. 3 Lipid metabolism may be of particular importance for the nervous system, as this organ has the second highest concentration of lipids, exceeded only by adipose tissue. Many neurological disorders, including bipolar disorders and schizophrenia, and neurodegenerative diseases such as Alzheimer ' s, Parkinson ' s and Niemann-Pick diseases, involve deregulated lipid metabolism. 3 
Focal Cerebral Ischemia (Stroke)
Stroke is the leading cause of long-lasting disability and the third leading cause of death in the United States. Approximately 3.9 million Americans are stroke survivors, and the aftereffects of stroke require more than $51 billion in health care costs annually. Presently, tissue plasminogen activator (tPA) is the only drug approved by the US Food and Drug Administration for the treatment of acute ischemic stroke; it needs to be administered within 3 hours of stroke onset. 19 However, there are some concerns that tPA has neurotoxic side effects in addition to its benefi cial (thrombolytic) actions. 20 Thus, there is a pressing need to identify therapeutic targets and develop new stroke treatments. Altered lipid metabolism is believed to contribute to cerebral ischemic injury. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Lipidomics holds the promise of characterizing complex mixtures of lipids, identifying previously unknown changes in lipid metabolism, and opening new opportunities for drug development. 33 
Biochemical Changes in Cerebral Ischemia
Cerebral ischemia is characterized by an obstruction of blood fl ow to the brain, resulting in loss of glucose and oxygen supply. The energy needs of the brain are supplied by metabolism of glucose and oxygen for the phosphorylation of ADP to ATP. Most of the ATP generated is used in the brain in maintaining intracellular homeostasis and transmembrane ion gradients of sodium, potassium, and calcium. Energy failure results in rapid loss of ATP and uncontrolled leakage of ions across the cell membrane that results in membrane depolarization and release of the neurotransmitters such as dopamine and glutamate. 33 , 34 Glutamate stimulates neuronal receptors, resulting in elevated intracellular Ca 2+ and activation of phospholipase A 2 (PLA 2 ) and phosphatidylinositol (PtdIns)-phospholipase C (PtdIns-PLC) 35 ( Figure 2 ). Cerebral ischemia also results in activation of phosphatidylcholine (PtdCho)-phospholipase C (PtdCho-PLC) and PtdCho-phospholipase D (PLD).
In addition to serving as important structural components of cellular membranes, phospholipids are reservoirs of cellular messengers. 41 Activation of various phospholipases hydrolyzes membrane phospholipids to release second messengers 1,2-diacylglycerol (DAG), phosphatidic acid (PA), lyso-PA, and arachidonic acid (ArAc). ArAc enhances glutamate release as well as depolarization-evoked Ca 2+ accumulation. 42 , 43 ArAc can also stimulate sphingomyelinase to produce ceramide. 44 Ceramide induces apoptosis 32 , 45-49 by inhibiting the mitochondrial electron transport 50 and releasing cytochrome c. 51 Cytochrome c initiates the apoptotic cellular death cascade by activation of caspase-3. [50] [51] [52] [53] Cardiolipin is an exclusive inner mitochondrial phospholipid enriched with unsaturated fatty acids and is essential for mitochondrial electron transport. 54 Studies have indicated that degradation of mitochondrial phospholipids also occurs and could affect the cellular energy metabolism via mitochondrial functions during ischemia/reperfusion. 13 , 55 , 56 Loss of cardiolipin has been implicated as a causative factor in mitochondrial dysfunction and release of cytochrome c. 13 Another lipid alteration implicated in initiation of apoptosis is translocation of phosphatidylserine (PtdSer) from the inner to the outer leafl et of the membrane lipid bilayer. 57 , 58 We have previously demonstrated signifi cant loss of PtdCho, PtdIns, PtdSer, sphingomyelin, and cardiolipin, along with alterations in the fatty acid composition of PtdCho and PtdEtn, phosphatidyl ethanolamine, in transient cerebral ischemia. 30 
Alterations in Lipid Metabolism After Stroke
We have recently demonstrated activation of phospholipases and signifi cant loss of PtdCho in a stroke model (transient focal cerebral ischemia). 25 PtdCho homeostasis is regulated by the balance between hydrolysis and synthesis. PtdCho is hydrolyzed by PLA 2 , PtdCho-PLC, and PLD. PtdCho synthesis is rate-limited by CTP (cytidine triphosphate):phosphocholine cytidylyltransferase (CCT) that makes cytidine-5 ′ -diphosphocholine (CDP-choline). The fi nal step of PtdCho synthesis is catalyzed by CDPcholine:1,2-diacylglycerol choline phosphotransferase. In the brain, PtdCho synthesis is predominantly through the CDP-choline pathway. Inhibition of PtdCho synthesis through inactivation of CCT is suffi cient to induce cell death. 41 Transient focal cerebral ischemia signifi cantly increased PLA 2 activity, secretory PLA 2 (sPLA 2 ) IIA mRNA and protein levels, PtdCho-PLC activity, and PLD2 protein expression following reperfusion. CDP-choline treatment signifi cantly attenuated PLA 2 activity, sPLA 2 IIA mRNA and protein levels, and PtdCho-PLC activity but did not affect PLD2 protein expression. Stroke also resulted in loss of CCT activity and CCT ␣ protein that was partially restored by CDP-choline. No changes were observed in the cPLA 2 (cytosolic PLA 2 ) or calcium-independent PLA 2 protein levels. The upregulation of phospholipases (A 2 , C, and D) and downregulation of CCT ␣ collectively resulted in the loss of PtdCho, which was signifi cantly restored by CDP-choline treatment. CDP-choline treatment significantly attenuated the infarction volume by 55% ± 5 after 1 hour of tMCAO (transient middle cerebral artery occlusion) and 1 day of reperfusion. Taken together, these results suggest that CDP-choline signifi cantly restores PtdCho levels by differentially affecting sPLA 2 IIA, PtdCho-PLC, and CCT ␣ after transient focal cerebral ischemia.
Reactive Oxygen Species and Lipid Peroxidation
ArAc released by the action of phospholipases is either reincorporated into membranes or metabolized by cyclooxygenases/lipoxygenases to form prostaglandins, leukotrienes, and reactive oxygen species (ROS) ( Figure 2 ). 59 ROS formed by ArAc metabolism generate lipid peroxides and the cytotoxic byproducts malondialdehyde, 4-hydroxynonenal (HNE), 60 and acrolein, 61 , 62 which covalently bind to cellular proteins and alter their function. The time course of alterations in lipid metabolism and formation of lipid metabolites and lipid peroxidation products after transient cerebral ischemia is presented in Figure 3 . 21 , 22 , 24 , 25 , 27 , 28 , 63 , 64 
Docosahexaenoic Acid and 10,17 S -docosatriene (Neuroprotectin D1) in Stroke
Release of lipid second messengers after neuronal injury can promote either further neuronal injury or neuroprotection. A limited number of papers have been published applying lipidomic approaches to the analysis of brain lipid metabolism in stroke models or neurodegenerative diseases. Cerebral ischemia results in rapid accumulation of free fatty acids, including ArAc (20:4) and docosahexaenoic acid (DHA, 22:6), although the specifi c phospholipases involved in this have not been fully characterized. Free fatty acids can be released by the direct action of various PLA 2 isoforms (of which nearly 20 have been characterized 65 ), by 
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hydrolysis of phospholipids by PtdCho-PLC and PtdIns-PLC to give DAG, followed by hydrolysis by DAG-lipases, or PLD to give phosphatidic acid, which can be hydrolyzed to DAG. This could also suggest that ArAc and DHA are liberated by phospholipases other than cPLA 2 (eg, sPLA 2 , which has a preference for PtdEtn, which has a high content of ArAc and DHA in the brain). 30 Bazan ' s group has studied the role of PLA 2 and PLA 2 hydrolysis products and identifi ed the DHA metabolite 10,17 S -docosatriene (neuroprotectin D1 [NPD1]) following cerebral ischemia/reperfusion in mouse. NPD1 was found to serve an endogenous neuroprotective role by inhibiting apoptotic DNA damage, upregulating antiapoptotic proteins Bcl-2 and BclxL, and downregulating proapoptotic Bax and Bad expression. NPD1 also inhibited oxidative stress-induced caspase-3 activation and IL (interleukin)-1 ␤ -stimulated cyclooxygenase-2 expression. 15 , 36-40 Administration of albumin causes systemic mobilization of n-3 polyunsaturated fatty acids, including DHA, and provides substantial neuroprotection in models of brain ischemia and trauma. It was demonstrated that after DHA-albumin administration there was an increase in NPD1 in the ipsilateral brain at 20 hours of reperfusion after 2 hours of transient middle cerebral artery occlusion in rat. 10 
Mass Spectroscopy and Lipid Peroxidation Products
Several studies demonstrating increased lipid peroxidation, DNA oxidation, and protein oxidation in Alzheimer ' s disease provide an increasing amount of evidence supporting a role for oxidative damage in this disorder. 66 Beyond damage to membranes, lipid peroxides give rise to reactive ␣ , ␤ -unsaturated aldehydes, including HNE and acrolein. These aldehydes covalently bind to proteins through reaction with thiol groups. Recently, HPLC coupled with ESI/tandem mass spectroscopy was used to measure HNE and acrolein in several brain regions from patients affected by mild cognitive disorder and early Alzheimer ' s disease. These studies demonstrated increased levels of HNE and acrolein 66 in the brain tissue in both neurological disorders, indicating that lipid peroxidation occurs early in the pathogenesis of Alzheimer ' s disease. 66 While generation of HNE has been demonstrated by our group 24 , 29 and others, 67 , 68 to the best of our knowledge no study has examined free acrolein formation in brain tissue after stroke. Recently, elevated levels of an acrolein-protein conjugate ( N ⑀ -(3-formyl-3,4-dehydropiperidino)-lysine, FDP-lysine) 61 , 69 were demonstrated in plasma of stroke patients using ACR-Lysine Adduct ELISA System (NOF Corporation, Tokyo, Japan). 70 In addition to its formation as a lipid peroxidation byproduct, acrolein is a ubiquitous environmental contaminant that is present in automobile exhaust and formed by the burning of fats during cooking. 71 Acrolein, by far the strongest electrophile among all ␣ , ␤ -unsaturated aldehydes, reacts with DNA bases including guanine, adenine, cytosine, and thymidine to form cyclic adducts, the major exocyclic adduct being acrolein-deoxyguanosine. These aldehyde-DNA Figure 3 . Time course of changes related to cytokines, lipid metabolism, and oxidative stress after transient brain ischemia. 21 , 22 , 24 , 25 , 27 , 28 , 63 , 64 PLA 2 enzyme activity, mRNA and protein expression, and PLD2 protein expression were increased after ischemia/reperfusion. CCT catalyzes the rate-limiting step in the biosynthesis of phosphatidylcholine. CCT activity and expression of CCT ␣ protein decreased following ischemia/reperfusion. Activation of phospholipases and loss of CCT collectively resulted in loss of PtdCho. ↑ = increase, ↓ = decrease, compared with shams. ArAc indicates arachidonic acid; CCT ␣ , cytidine triphosphate:phosphocholine cytidylyltransferase-␣ ; GSSG, oxidized glutathione; HNE, 4-hydroxynonenal; IL-1 ␤ , interleukin-1 ␤ ; LTC 4 , leukotriene C 4 ; MDA, malondialdehyde; • OH, hydroxyl radical; PGE 2 , prostaglandin E 2 ; PLA 2 , phospholipase A 2 ; PLD2, phospholipase D2; TNF-␣ , tumor necrosis factor-␣ .
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lesions may have a role in mutagenesis and carcinogenesis, and contribute to the pathogenesis of neurodegenerative diseases. 71 Analysis of adducts in DNA requires methods with high selectivity and sensitivity since the level of DNA adduction in biological samples is typically 1 adduct in 10 6 to 10 9 normal nucleotides. 32 P-postlabeling methods, in which ␥ -32 P-ATP of high specifi c activity is used to label adducted and normal nucleotides with a radioactive phosphorous group, provide high sensitivity but cannot provide structural information and require working with a high-energy isotope. Increased levels of acrolein-deoxyguanosine adducts were recently demonstrated in brain tissue from Alzheimer ' s disease patients using capillary HPLC coupled with nanoelectrospray isotope dilution tandem mass spectrometry. 71 This method was highly sensitive and had a detection limit of 50 adducts/10 9 nucleotides using 10 µg of DNA.
CONCLUSIONS: LIPIDOMICS AND RNA SILENCING AT A CROSSROADS
RNA interference 72 , 73 takes advantage of a naturally occurring process to degrade RNA, the intermediary translator between the DNA of genes and the protein molecules they encode. By degrading RNA, genes can be selectively and temporarily " turned off. " RNA silencing provides a tool to analyze protein function and is a method of choice particularly for genes where transgenic knockouts are not possible because of lethality, for example CCT ␣ 74 and PLD. 75 RNA interference may provide a powerful tool together with lipidomic analyses to elucidate the specifi c roles of lipid intermediates in cell signaling; already these approaches have provided crucial information that was previously unachievable. 76 
